Skip to main content

Table 3 Association of UA*, UA/Cr ratio* with COVID-19 and gender

From: Association of serum uric acid levels with COVID-19 severity

 

Model 1

Model 2

Model 3

β (95% CI)

β (95% CI)

β (95% CI)

UA#

COVID-19

−0.25† (− 0. 20, − 0.10)

−0.21† (− 0.20, − 0.06)

−0.15† (− 0.17, − 0.01)

Male

0.50† (0.22, 0.31)

0.53† (0.22, 0.33)

0.47† (0.19, 0.30)

COVID-19*Male

–

−0.06 (− 0.15, 0.06)

−0.001 (− 0.10, 0.10)

AIC

−79.27

−78.03

− 111.46

BIC

−63.68

−58.54

− 72.49

UA/Cr ratio#

COVID-19

−0.21† (− 0.16, − 0.06)

−0.13 (− 0.13, 0.01)

−0.06 (− 0.11, 0.05)

Male

−0.12† (− 0.10, − 0.01)

−0.07 (− 0.09, 0.02)

−0.08 (− 0.09, − 0.02)

COVID-19*Male

–

−0.13 (− 0.20, − 0.01)

−0.11 (− 0.18, 0.02)

AIC

−68.02

−69.28

−83.80

BIC

− 52.43

−49.80

−48.72

  1. Note: Linear regression analysis was used to assess association of UA*, UA/Cr ratio* with COVID-19 and gender
  2. Abbreviations: AIC Akaike information criterion, BIC Bayesian Information Criterions
  3. Model 1: Including COVID-19 and gender
  4. Model 2: Including Model 1 and COVID-19*gender
  5. Model 3 of UA#: Including Model 2 and LEU#†, LYM%†, eGFR#†, ALB/GLB, FPG†
  6. Model 3 of UA/Cr ratio#: Including Model 2 and LEU#†, LYM%†, ALB/GLB, FPG
  7. The P-values are for the beta coefficient
  8. a#: The data were transformed into Ln (a)
  9. †P <0.05